GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
40.75
+1.90 (4.89%)
At close: May 15, 2026, 4:00 PM EDT
41.00
+0.25 (0.61%)
After-hours: May 15, 2026, 7:59 PM EDT

GeneDx Holdings Revenue

GeneDx Holdings had revenue of $102.25M in the quarter ending March 31, 2026, with 17.38% growth. This brings the company's revenue in the last twelve months to $442.68M, up 34.09% year-over-year. In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth.

Revenue (ttm)
$442.68M
Revenue Growth
+34.09%
P/S Ratio
2.61
Revenue / Employee
$340,522
Employees
1,300
Market Cap
1.21B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.54M122.09M39.97%
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019196.17M62.83M47.12%
Dec 31, 2018133.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
NeoGenomics745.97M
OPKO Health581.12M
Veracyte541.74M
CareDx412.82M
Twist Bioscience409.48M
Castle Biosciences339.92M
Fulgent Genetics320.35M
Revenue Rankings